What do we know about the antibody responses to SARS-CoV-2?

ABSTRACT: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide causing a pandemic with millions of infected people and deaths. Currently, the scientific community is working hard to develop a specific vaccine or treatment. However, since antibody production is an important part of the adaptive immune response, to develop vaccines and therapies, we must understand the antibody response to SARS-CoV-2 infection. In this work, we summarize the most important findings of antibody-mediated immunity against SARS-CoV-2 and highlight its role in the efficient use of plasma from convalescent patients and the direct application of antibodies as treatment.

SUBMITTER: Lagunas-Rangel FA 

PROVIDER: S-EPMC7826124 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature